Mckesson Corp
NYSE:MCK
Mckesson Corp
NYSE:MCK
Price:
531.1 USD
-1.14%
Market Closed
Updated:
May 2, 2024
P/E
Price to Earnings
Price to Earnings
23.2
Current
16.6
Median
23.2
Industry
Higher
than median
Lower
than industry value
Price to Earnings (P/E) ratio is a valuation multiple that compares a company’s market capitalization to its net income. It indicates the dollar amount an investor can expect to invest in a company in order to receive $1 of that company’s earnings.
P/E
=23.2
Market Cap
/
69.6B
Net Income
3B
All Countries
| Market Cap | P/E | ||||
|---|---|---|---|---|---|
| US |
|
Mckesson Corp
NYSE:MCK
|
69.6B USD | 23.2 | |
| US |
|
Cencora Inc
NYSE:COR
|
45.7B USD | 24.5 | |
| US |
|
Amerisourcebergen Corp
NYSE:ABC
|
35.4B USD | 20.9 | |
| US |
|
Cardinal Health Inc
NYSE:CAH
|
24.9B USD | 39 | |
| US |
|
Henry Schein Inc
NASDAQ:HSIC
|
8.9B USD | 21.4 | |
| KR |
C
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW | 89.6 | |
| CN |
|
Huadong Medicine Co Ltd
SZSE:000963
|
57.6B CNY | 21.3 | |
| CN |
|
Sinopharm Group Co Ltd
HKEX:1099
|
60.6B HKD | 6.3 | |
| IT |
|
Amplifon SpA
MIL:AMP
|
7.1B EUR | 45.7 | |
| CN |
S
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
51B CNY | 13.5 | |
| DE |
M
|
McKesson Europe AG
XHAM:CLS1
|
5B EUR | -5.1 |
P/E Forward Multiples
Forward P/E multiple is a version of the P/E ratio that uses forecasted net income for the P/E calculation. 1-Year, 2-Years, and 3-Years forwards use net income forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
P/E
19
2-Years Forward
P/E
16.9
3-Years Forward
P/E
14.9
You don't have any saved screeners yet
